Form 4: OneMedNet Director Casaburi Boosts Stake to 110,475 Shares

OneMedNet Director Eric Casaburi significantly increased his beneficial ownership of common stock through a series of open market purchases and restricted stock unit grants.

Summary

• Director Eric Casaburi of OneMedNet Corp (ONMD) reported a series of transactions increasing his beneficial ownership of common stock.
• Transactions include the acquisition of 90,000 Restricted Stock Units (RSUs) as director compensation for fiscal years 2024 and 2025.
• The 2024 RSUs (45,000 shares) were granted on January 19, 2024, and vested on December 31, 2024.
• The 2025 RSUs (45,000 shares) were granted on November 26, 2025, and are scheduled to vest on December 31, 2025, subject to continued service.
• Casaburi also made several open market purchases of common stock, totaling 20,475 shares.
• These purchases occurred between February 16, 2024, and October 15, 2025, at prices ranging from $0.72 to $3.05 per share.
• Following these reported transactions, Casaburi's total beneficial ownership of OneMedNet common stock stands at 110,475 shares.
• All transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 8

Explanation: The significant increase in director ownership, particularly through open market purchases at various price points, including a higher price, indicates strong insider confidence in the company's future prospects and valuation.

Positives

• Director Eric Casaburi significantly increased his beneficial ownership, signaling strong confidence in OneMedNet's future.
• The increase includes substantial open market purchases totaling 20,475 shares, demonstrating a direct investment of personal capital.
• A notable purchase of 10,000 shares was made at $3.05, indicating a belief in the stock's value at a higher price point.
• The grant of 90,000 Restricted Stock Units (RSUs) aligns the director's interests with long-term shareholder value.

Negatives

• No negative information is presented in this Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

The filing indicates future vesting of 45,000 Restricted Stock Units on December 31, 2025, contingent on the reporting person's continued service with the issuer.

Industry Context

This insider transaction report does not provide information directly related to broader industry trends or competitor analysis. It focuses solely on the beneficial ownership changes of a specific director.

Related Party Transactions

• The Restricted Stock Unit grants represent director compensation under the company's 2022 Equity Incentive Plan.

Stakeholder Impact

• Increased director ownership can signal confidence to shareholders, potentially influencing investor sentiment positively.
• The alignment of director interests with long-term company performance through RSU grants benefits shareholders.

Next Steps

• Vesting of 45,000 Restricted Stock Units on December 31, 2025, subject to continued service.

Key Dates

Recommendation

The substantial increase in director Eric Casaburi's beneficial ownership, including significant open market purchases at varying prices up to $3.05, signals strong insider confidence in OneMedNet's future performance and valuation. Such insider buying, especially under a Rule 10b5-1 plan, often precedes positive developments and is generally viewed as a bullish indicator by seasoned investors.

Keywords

OneMedNet, ONMD, Form 4, insider trading, director ownership, stock acquisition, RSU, beneficial ownership